Assignee
NORGINE BV
NL·18 granted patents·13 pending applications·66 citations·filing 2002–2021
Top patents by PatentIndex Score
31 records- 0192US7658914B2Colon cleansing compositionsNORGINE BV·Filed 2006·Granted Feb 9, 2010·21 cites·31 claims
- 0291US9707297B2CompositionsNORGINE BV·Filed 2016·Granted Jul 18, 2017·10 cites·24 claims
- 0391US9326969B2CompositionsNORGINE BV·Filed 2015·Granted May 3, 2016·9 cites·20 claims
- 0490US10016504B2CompositionsNORGINE BV·Filed 2017·Granted Jul 10, 2018·7 cites·20 claims
- 0590US8999313B2CompositionsNORGINE BV·Filed 2014·Granted Apr 7, 2015·11 cites·30 claims
- 0684US10918723B2Colon cleansing compositions and methods of useNORGINE BV·Filed 2017·Granted Feb 16, 2021·1 cites·30 claims
- 0782US10792306B2Colonoscopy—preparationNORGINE BV·Filed 2020·Granted Oct 6, 2020·1 cites·30 claims
- 0882US10780112B2Colonoscopy-preparationNORGINE BV·Filed 2020·Granted Sep 22, 2020·1 cites·30 claims
- 0981US10646512B2Colonoscopy - preparationNORGINE BV·Filed 2017·Granted May 12, 2020·1 cites·16 claims
- 1078US12083179B2Colon cleansing compositions and method of useNORGINE BV·Filed 2021·Granted Sep 10, 2024·0 cites·20 claims
- 1174US7858617B22-oxy-benzoxazinone derivatives for the treatment of obesityNORGINE BV·Filed 2008·Granted Dec 28, 2010·1 cites·15 claims
- 1272US11529368B2Colonoscopy—preparationNORGINE BV·Filed 2020·Granted Dec 20, 2022·0 cites·19 claims
- 1368US2010086624A1Colon cleansing compositions and methodsNORGINE BV·Filed 2009·Application pending·0 cites
- 1466US7825113B22-oxy-benzoxazinone derivatives for the treatment of obesityNORGINE BV·Filed 2002·Granted Nov 2, 2010·2 cites·23 claims
- 1566US2018311361A1CompositionsNORGINE BV·Filed 2018·Application pending·0 cites
- 1664US2014186470A1CompositionsNORGINE BV·Filed 2014·Application pending·0 cites
- 1759US9969687B2Compounds useful as CCR9 modulatorsNORGINE BV·Filed 2014·Granted May 15, 2018·1 cites·23 claims
- 1858US2016184263A1CompositionsNORGINE BV·Filed 2015·Application pending·0 cites
- 1957US8613948B2Treatment of faecal incontinence and other conditions with 1R, 2S-methoxamineNORGINE BV·Filed 2012·Granted Dec 24, 2013·0 cites·3 claims
- 2054US2010297263A1Colon cleansing compositions and methodsNORGINE BV·Filed 2010·Application pending·0 cites
- 2153US2010196513A1Colon cleansing compositions and methodsNORGINE BV·Filed 2010·Application pending·0 cites
- 2253US2010189815A1Colon cleansing compositions and methodsNORGINE BV·Filed 2010·Application pending·0 cites
- 2351US2017296575A1Formulations comprising polyethylene glycolNORGINE BV·Filed 2017·Application pending·0 cites
- 2450US7776853B22-amino-benzoxazinone derivatives for the treatment of obesityNORGINE BV·Filed 2002·Granted Aug 17, 2010·0 cites·36 claims
- 2549US9468686B2Solutions comprising polyethylene glycol and electrolytesNORGINE BV·Filed 2014·Granted Oct 18, 2016·0 cites·27 claims
- 2647US2016193245A1Formulations comprising polyethylene glycolNORGINE BV·Filed 2016·Application pending·0 cites
- 2745US8513023B2Prognostic methodNORGINE BV·Filed 2012·Granted Aug 20, 2013·0 cites·9 claims
- 2845US2014178477A1Solid preparationNORGINE BV·Filed 2014·Application pending·0 cites
- 2942US2016228467A1Peg or peg block copolymer for treating colorectal cancerNORGINE BV·Filed 2016·Application pending·0 cites
- 3039US2018230098A1Compounds useful as ccr9 modulatorsNORGINE BV·Filed 2018·Application pending·0 cites
- 3135US2017002011A1Benzene sulfonamides as ccr9 inhibitorsNORGINE BV·Filed 2014·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →